United States · FDA National Drug Code directory
Haloperidol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-474_f3409439-088d-49ec-9e10-c6c3b1a07eef
- Product NDC
- 63323-474
- Form
- INJECTION, SOLUTION
- Composition / generic term
- HALOPERIDOL LACTATE
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20001020
- Source listing expiry
- 20261231
Source-listed ingredients
- HALOPERIDOL LACTATE — 5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 TRAY (63323-474-01) / 1 mL in 1 VIAL (63323-474-00) · 63323-474-01
- 1 VIAL, MULTI-DOSE in 1 BOX (63323-474-10) / 10 mL in 1 VIAL, MULTI-DOSE · 63323-474-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →